Scholarly Index
Doug Chapman
Pfizer (United States); 836 total citations; 27 total publications; best world rank #280
Pfizer (United States)
836Total citations
27Total publications
16H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 505 | US 166 | 84.50 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 907 | US 319 | 73.85 |
| Dermatological and Skeletal Disorders | 2021-2025 | 280 | US 72 | 66.84 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 860 | US 133 | 41.19 |